Multiple Sclerosis [MS]
No in-app products collected for this app.
| Rating | |||
|---|---|---|---|
| Canada | 13%2 | 3.00 | |
| Australia | 6%1 | 2.00 | |
| Brazil | 6%1 | 5.00 | |
| Germany | 6%1 | 5.00 | |
| Spain | 6%1 | 4.00 | |
| United Kingdom | 6%1 | 3.00 | |
| Hong Kong | 6%1 | 5.00 | |
| Indonesia | 6%1 | 1.00 | |
| Japan | 6%1 | 1.00 | |
| Mexico | 6%1 | 2.00 | |
| Netherlands | 6%1 | 5.00 | |
| New Zealand | 6%1 | 1.00 | |
| Saudi Arabia | 6%1 | 5.00 | |
| Thailand | 6%1 | 4.00 | |
| United States | 6%1 | 5.00 |
Description
@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Sclerosis @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care.
With Cognitive AI, clinicians use @Point of Care to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care.
Multiple Sclerosis @Point of Care™ is designed to:
Support discovery and practice change
Provide relevant, evidence-based disease-specific medical content
Improve patient outcomes at the point of care
Features:
Continually updated multiple sclerosis content
Topics in diagnosis, treatment, and care management developed with expert physician authors
Case studies, videos, and interviews
Access to actionable patient-recorded data
Detailed reference list with access to original sources
Continuing medical education credit (CME/CE)
Surveys and peer polling
Patient education resources to share with patients